Published: 25th May, 2020
A recent medical technique, known as less invasive surfactant administration (LISA), has been developed for treatment of lung disease or respiratory distress syndrome among premature babies.
- A recent medical technique, known as less invasive surfactant administration (LISA), has been developed for treatment of lung disease or respiratory distress syndrome among premature babies.
- LISA has been developed as a lung protective strategy for respiratory management and ventilation in view of the mechanical ventilation causing damage to the preterm lungs of newborns.
- The procedure, started initially for newborn children with the birth weight of less than 1,500 grams, has yielded encouraging results.
- Infants considered suitable for LISA are those being managed with primary continuous positive airway pressure (CPAP) or high flow with the evidence of increasing respiratory distress and with a rising oxygen requirement.
- The regular application of LISA would turn out to be very useful and help save the lives of premature babies.
Courses
Study
Notes
Home
Resources
More
